Notice of Completion of Acquisition of Own Shares
(WorldNews Japan)

Press Release Notice of Completion of Acquisition of Own Shares (Under the provision of its Articles of Incorporation in accordance with Article 165, paragraph 2 of the Companies Act) Tokyo, September 21, 2018 -Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D, "the Company") announced that it completed acquisition of its own shares, which was resolved by its Board of Directors on May 31, 2018, pursuant to Article 156 which is applicable in accordance with Article 165, paragraph 3 of the Companies Act. Particulars 1. Class of shares acquired: 2. Total...